CSL
Manufacturing · Australia · 32,698 Employees
View Company Info for Free
About
Headquarters
655 Elizabeth St, Melbourne, Victoria, 3000, Au...Phone Number
+61 393891911Website
www.seqirus.comRevenue
$14.7 BillionStock Symbol
CSL.AXIndustry
Most Recent Scoops
Who is CSL
CSL Org Chart
Is CSL your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if CSL had a recent Job posting/layoffs
CSL, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when CSL launches new products
Funding: Get notified immidiatlly once CSL has new funding data
Congratulate Masked Content for being promoted to Masked Content at CSL
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on CSL recently announced quarterly report
Check if CSL has recently received funding, and reach out quickly before it becomes old news!
Check out if CSL is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to CSL
Compare insights from companies similar to CSL, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CSL Email Formats
CSL uses at least 5 email formats with first.last (ex. John.Smith@cslbehring.com) being used 79.5% of the time
CSL Email Formats | Percentage | |
---|---|---|
first.last | John.Smith@cslbehring.com | 79.5% |
first.last | John.Smith@csl.com.au | 11.4% |
first.last | John.Smith@cslbehring.com.au | 3% |
first.last | John.Smith@cslplasma.com | 2% |
first + last | JohnSmith@cslbehring.com |
Get Verified Emails
CSL Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
CSL Tech Stack
A closer look at the technologies used by CSL
Most Recent Scoops
CSL News & Media
Pediatric Vaccine Market Research Report 2025: Merck & Co. Leads Highly Concentrated Market, Holding 30.82% Share, Followed by Sanofi, Pfizer, Seqirus, GSK
Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Pediatric Vaccine Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering. This report describes and explains the pediatric vaccine market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and for the major economies within each region. The global pediatric vaccine market reached a value of nearly $41.16CSL Limited (CSLLY) Q2 2025 Earnings Call Transcript
CSL Limited (OTCQX:CSLLY) Q2 2025 Results Earnings Conference Call February 10, 2025 7:00 PM ETCompany ParticipantsChris Cooper - Vice President and Head of...Falling US flu vaccine rates hurt Australia's CSL profit growth
(Reuters) -Australian biopharmaceutical company CSL said on Tuesday that falling immunisation rates in the U.S., its largest market, weighed on its vaccine sales and first-half profit growth, sending its shares lower. CSL, the world's second-largest maker of flu vaccines, also warned that the trend of lower immunisation posed a public health risk for the U.S. CEO Paul McKenzie said post-COVID apathy among 18-to-64-year-olds in the U.S., as well as reduced vaccine access,CSL Behring's Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Hemophilia B
94 percent of patients eliminated factor IX prophylaxis and remained free of continuous prophylaxis through four years post-treatment Mean factor IX activity levels were sustained at near normal levels of 37% through four years post-treatment, reinforcing the efficacy of HEMGENIX in the...
Top Companies in Australia
Top 10 companies in Australia by revenue
Top 10 companies in Australia by number of employees
Top 10 companies in Australia by total funding amount
Frequently Asked Questions Regarding CSL
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies.... Read More